Press release
Future of the Viscosupplementation Market: Trends, Innovations, and Key Forecasts Through 2034
Viscosupplementation
Viscosupplementation Market Size Growth Forecast: What to Expect by 2025?
In recent times, the viscosupplementation market has seen robust growth. The market is projected to expand from $4.1 billion in 2024 to $4.5 billion in 2025, registering a compound annual growth rate (CAGR) of 9.8%. Factors such as an aging demographic, escalating obesity levels, improved insurance coverage, rising awareness, patient predilections, and a surge in osteoarthritis instances have contributed to the historical growth.
How Will the Viscosupplementation Market Size Evolve and Grow by 2029?
The market size for viscosupplementation is projected to experience swift expansion in the forthcoming years. An estimation suggests its growth to reach "$6.67 billion by 2029 with a compound annual growth rate (CAGR) of 10.3%. The projected increase during the forecast period can be tied to several factors such as regulatory backing, alternative payment frameworks, heightened healthcare spending, research and development initiatives, and expansion of indications. Key trends during the forecast period consist of the implementation of outcome-centric payment models, initiatives for patient education, development of biomarkers, research in gene therapy, and the adoption of value-based healthcare models.
View the full report here:
https://www.thebusinessresearchcompany.com/report/viscosupplementation-global-market-report
What Drivers Are Propelling the Growth of Viscosupplementation Market Forward?
An increase in osteoarthritis occurrences is anticipated to accelerate viscosupplementation market growth. Osteoarthritis, a degenerative joint disorder also known as a common type of arthritis, leads to the deterioration of joints, often in the hips, knees, and hands. By directly injecting hyaluronic acid into bone joints, viscosupplementation treatment aids in alleviating pain and promoting seamless bone movement, thus enhancing bone functionality and mitigating pain. For example, the Centers for Disease Control and Prevention (CDC), a US public health organization, predicts that by 2040, around 78.4 million adults aged 18 and above in the USA will be afflicted with arthritis. Consequently, the escalating instances of osteoarthritis are fuelling the expansion of the viscosupplementation market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9836&type=smp
What Long-Term Trends Will Define the Future of the Viscosupplementation Market?
Leading businesses in the viscosupplementation market are emphasizing the creation of novel products such as hyaluronic acid resorbable scaffolds. These new products aim to boost joint lubrication, foster tissue regeneration, and offer enduring relief from symptoms of osteoarthritis. This innovation is intended to enhance patient's quality of life and broaden the range of treatment alternatives. A resorbable hyaluronic acid scaffold refers to a biodegradable and biocompatible structure primarily composed of hyaluronic acid (HA), a polysaccharide that naturally exists in connective tissues. For instance, in May 2023, Anika Therapeutics, Inc., a US-based firm providing orthopedic services, launched Hyalofast, a ready-to-use, resorbable hyaluronic acid scaffold for repairing cartilage. Hyalofast is designed as a hyaluronic acid-based solution focusing on joint conservation, serving as a potentially less invasive alternative to major surgical interventions.
What Are the Key Segments in the Viscosupplementation Market?
The viscosupplementation market covered in this report is segmented -
1) By Type: Single Injection Viscosupplementation, Three Injection Viscosupplementation, Five Injection Viscosupplementation
2) By Source: Avian Origin, Non-Avian Origin
3) By Hyaluronic Acids: Standard Hyaluronic Acid, Stabilized Hyaluronic Acid
4) By Application: Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis
5) By End-User: Hospitals, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Single Injection Viscosupplementation: Hyaluronic Acid-Based Products, Non-Hyaluronic Acid Products
2) By Three Injection Viscosupplementation: Hyaluronic Acid-Based Products, Combination Products
3) By Five Injection Viscosupplementation: Hyaluronic Acid-Based Products, Combination Products
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9836&type=smp
Who Are the Key Players Shaping the Viscosupplementation Market's Competitive Landscape?
Major companies operating in the viscosupplementation market include Seikagaku Corporation, Anika Therapeutics Inc., Bioventus LLC, Zimmer Biomet, Johnson & Johnson Services Inc., Aptissen S.A., Smith & Nephew Plc., Flexion Therapeutics Inc., Regen Lab SA, OrthogenRx Inc., Fidia Farmaceutici S.P.A, Ferring Pharmaceuticals, Laboratoires VIVACY, Allergan, Hyalgan, Synvisc, Euflexxa, Sanofi S.A., Wellchem Pharmaceuticals Pte Ltd., SingHealth Group
What Geographic Markets Are Powering Growth in the Viscosupplementation Market?
North America was the largest region in the viscosupplementation market in 2024. The regions covered in the viscosupplementation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9836
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Future of the Viscosupplementation Market: Trends, Innovations, and Key Forecasts Through 2034 here
News-ID: 4180250 • Views: …
More Releases from The Business Research Company
Top Trends Transforming the Adult Vaccines Market Landscape in 2025: Data Trend …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Adult Vaccines Industry Market Size Be by 2025?
The market size for adult vaccines has seen a robust growth in the past few years. The market is predicted to rise from a value of $22.82 billion in 2024 to $24.21 billion in 2025, reflecting a compound…
Chronic Disease Rise Fuels Ethical Pharmaceutical Market Growth: A Key Catalyst …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Ethical Pharmaceuticals Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Over the past few years, the ethical pharmaceuticals market has seen considerable expansion. The projection is that it will increase from $7.15 billion in 2024 to $7.96 billion in 2025, at a compound annual growth…
Emerging Allergy Conjunctivitis Market Trends: Unveiling The Product Revolution …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Allergy Conjunctivitis Market Size Growth Forecast: What to Expect by 2025?
The market size of allergy conjunctivitis has experienced consistent growth in the past few years. It is projected to expand from $2.51 billion in 2024 to $2.63 billion in 2025, representing a compound annual growth rate (CAGR) of…
Protein Purification and Isolation: Core Growth Enabler in the Elevated Governme …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Protein Purification and Isolation Industry Market Size Be by 2025?
The market for protein purification and isolation has seen robust growth in recent years, increasing from $9.47 billion in 2024 to a projected $10.36 billion in 2025, with a compound annual growth rate (CAGR) of 9.4%.…
More Releases for Viscosupplementation
Viscosupplementation Market Report, History and Forecast 2023-2031
Newark, New Castle, USA - Growth Plus Reports has published a new report on Viscosupplementation Market, which includes a detailed analysis based on competitors and important market segments (2023-2031). The Global Viscosupplementation provides a thorough analysis of many segments such as opportunities, market size, developments, innovation, sales, and overall growth of leading players. The research is based on primary and secondary statistical data, and it includes both intuitive and statistical…
Hampering the growth of the viscosupplementation market 2021
Viscosupplementation is a minimally invasive procedure that involves injection of the hyaluronic acid injected into a knee joint to promote better joint development and lubrication. It also helps in reducing pain, irritation and helps in improving osteoarthritis condition. Hyaluronic acid (HA) or hyaluronate is a non-sulfated glycosaminoglycan that is distributed throughout the body in epithelial, connective tissues, and neural tissues. Increasing prevalence of osteoarthritis in people is expected to boost…
Understanding Impact of COVID-19 on Viscosupplementation Market
According to the report, the global viscosupplementation market was valued at ~US$ 2.6 Bn in 2018 and is projected to expand at a CAGR of ~7% from 2019 to 2027. Viscosupplementation can be performed using three primary injection types: single injection, three injections, and five injections. Applications of viscosupplementation injection include knee osteoarthritis, hip osteoarthritis, and hand osteoarthritis. Growth of the global viscosupplementation market can be attributed to rise in…
The three injection viscosupplementation product type segment is projected to be …
Russia’s healthcare infrastructure will continue witnessing significant rise in number of orthopaedic patients as several bone & joint-related disorders are likely to be caused by people’s eating & drink habits, their proactive lifestyles and the country’s harsh weather conditions. Rising occurrence of joint-related ailments such as knee osteoarthritis in Russia are a result of people performing physical labour in severely cold weather conditions. This has necessitated the adoption of viscosupplementation…
Viscosupplementation Market
The rising obesity rate, coupled with an increasing geriatric population in Russia is giving rise to an increasing number of cases of knee osteoarthritis. Prevalence of osteoarthritis in the adult population in Russia is approximately 13%. Knee osteoarthritis is causing disability in the ageing population and this is the precise reason for the rise in demand for viscosupplementation market. Considering this fact, a new market report titled “Viscosupplementation Market: Russia…
Viscosupplementation Market: Three Injection Viscosupplementation Likely to be t …
The rising obesity rate, coupled with an increasing geriatric population in Russia is giving rise to an increasing number of cases of knee osteoarthritis. Prevalence of osteoarthritis in the adult population in Russia is approximately 13%. Knee osteoarthritis is causing disability in the ageing population and this is the precise reason for the rise in demand for viscosupplementation market. Considering this fact, a new market report titled “Viscosupplementation Market: Russia…
